New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainMetastatic or leptomeningeal disease (LMD), the spreading of a brain cancer to the meninges, is a devastating cancer complicat
Oncology January 02,2024
Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainMetastatic or leptomeningeal disease (LMD), the spreading of a brain cancer to the meninges, is a devastating cancer complicat
Oncology January 02,2024
Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th
Oncology January 02,2024
Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th
Oncology January 02,2024
Artificial DNA kills cancer: Hairpin-shaped DNA binds with microRNA in cancer cells to trigger an immune response

Artificial DNA kills cancer: Hairpin-shaped DNA binds with microRNA in cancer cells to trigger an immune response

byUniversity of TokyoOncolytic DNA hairpin pairs (oHPs) are introduced to the cancer cell. When the oHPs encounter the tumor-causing overexpressed microRNA (miRNA), they unravel to connect with
Oncology January 02,2024
Artificial DNA kills cancer: Hairpin-shaped DNA binds with microRNA in cancer cells to trigger an immune response

Artificial DNA kills cancer: Hairpin-shaped DNA binds with microRNA in cancer cells to trigger an immune response

byUniversity of TokyoOncolytic DNA hairpin pairs (oHPs) are introduced to the cancer cell. When the oHPs encounter the tumor-causing overexpressed microRNA (miRNA), they unravel to connect with
Oncology January 02,2024
Conundrum solved over HPV link with head and neck cancer

Conundrum solved over HPV link with head and neck cancer

byUniversity of BirminghamElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainA major international trial published in
Oncology January 02,2024
Conundrum solved over HPV link with head and neck cancer

Conundrum solved over HPV link with head and neck cancer

byUniversity of BirminghamElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainA major international trial published in
Oncology January 02,2024
Man's best friend leads way to early cancer detection

Man's best friend leads way to early cancer detection

by Brittany Steff,Purdue UniversityVeterinary oncologist Deborah Knapp studies cancer in Scottish terriers to help advance the science of detecting and treating early cancer in both humans and d
Oncology January 02,2024
Man's best friend leads way to early cancer detection

Man's best friend leads way to early cancer detection

by Brittany Steff,Purdue UniversityVeterinary oncologist Deborah Knapp studies cancer in Scottish terriers to help advance the science of detecting and treating early cancer in both humans and d
Oncology January 02,2024
Population scientist identifies rapid rise in cervical cancer in millennial women

Population scientist identifies rapid rise in cervical cancer in millennial women

byMedical University of South CarolinaHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease
Oncology January 02,2024
Population scientist identifies rapid rise in cervical cancer in millennial women

Population scientist identifies rapid rise in cervical cancer in millennial women

byMedical University of South CarolinaHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease
Oncology January 02,2024
AI application in pathology reveals novel insights in endometrial cancer diagnostics

AI application in pathology reveals novel insights in endometrial cancer diagnostics

byLeiden Universityim4MEC deep learning pipeline. (A) Whole-slide images were segmented and cut into non-overlapping square tiles of 360 μm at 40× magnification and resized to 224 × 224 pixels.
Oncology January 02,2024
AI application in pathology reveals novel insights in endometrial cancer diagnostics

AI application in pathology reveals novel insights in endometrial cancer diagnostics

byLeiden Universityim4MEC deep learning pipeline. (A) Whole-slide images were segmented and cut into non-overlapping square tiles of 360 μm at 40× magnification and resized to 224 × 224 pixels.
Oncology January 02,2024
AI-guided personalized drug combinations to treat relapsed lymphoma

AI-guided personalized drug combinations to treat relapsed lymphoma

byNational University of SingaporeAsst Prof Anand Jeyasekharan (left) and Assoc Prof Edward Chow (right) from the Cancer Science Institute of Singapore at NUS are pioneering the application of Q
Oncology January 02,2024
AI-guided personalized drug combinations to treat relapsed lymphoma

AI-guided personalized drug combinations to treat relapsed lymphoma

byNational University of SingaporeAsst Prof Anand Jeyasekharan (left) and Assoc Prof Edward Chow (right) from the Cancer Science Institute of Singapore at NUS are pioneering the application of Q
Oncology January 02,2024
AI facilitates breakthrough in sinonasal cancer diagnostics

AI facilitates breakthrough in sinonasal cancer diagnostics

byLudwig Maximilian University of MunichMethylation array for the determination of DNA modifications. Credit: Jurmeister et al.Although tumors in the nasal cavity and the paranasal sinus are con
Oncology January 02,2024
AI facilitates breakthrough in sinonasal cancer diagnostics

AI facilitates breakthrough in sinonasal cancer diagnostics

byLudwig Maximilian University of MunichMethylation array for the determination of DNA modifications. Credit: Jurmeister et al.Although tumors in the nasal cavity and the paranasal sinus are con
Oncology January 02,2024
First multi-chamber heart organoids unravel human heart development and disease

First multi-chamber heart organoids unravel human heart development and disease

by IMBA- Institute of Molecular Biotechnology of the Austrian Academy of SciencesCross-section of a multi-chamber cardioid, with the atrial organoid in cyan, the left ventricular organoid in white and
Cardiovascular Diseases January 02,2024
First multi-chamber heart organoids unravel human heart development and disease

First multi-chamber heart organoids unravel human heart development and disease

by IMBA- Institute of Molecular Biotechnology of the Austrian Academy of SciencesCross-section of a multi-chamber cardioid, with the atrial organoid in cyan, the left ventricular organoid in white and
Cardiovascular Diseases January 02,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com